As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

Four years have passed since Arpa Studios – a fragrance brand and research project exploring scent and synaesthesia – was founded by polymath perfumer Barnabé Fillion. Wallpaper* previewed its debut ...

Scanlon responded, saying he “firmly” rejects Miller-Williams’ claim. “The American Rescue Plan of 2021 (ARPA) provided the City of Buffalo with an unprecedented opportunity to address the ...

Take a look at the top spending categories and explore nearly 500 projects in our searchable table. Excerpts of ARPA documents from Waldo and York counties; tree map of total county allocations.

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against the other healthcare stocks. McKinsey reported that, since 2019, the US healthcare industry ...

A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.

The U.S. government has handed Moderna almost $600 million to accelerate its work on various bird flu vaccines as well as work on mRNA vaccines for other influenza strains with pandemic potential.

There have been 67 confirmed human bird flu cases in the U.S. since April 2024. Moderna has been awarded approximately $590 million from the federal government to help speed up the development of ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent ...

Moderna has lowered 2025 revenue guidance after a tough 2024 coronavirus vaccination season. However, the company aims to launch 10 new products over the next few years -- and that could lead to ...

Moderna stock has been under pressure amid declining sales of its COVID-19 vaccine. The company projects optimism in its long-term outlook, believing that several pending product approvals can ...